Oral niacin
nicotinic acid: niacin 1500 mg po qd
0 participants analyzed for the overall number of baseline participants. The PI has retired and left the institution. Efforts were made to contact the PI but were unsuccessful. No study data are available for any results modules.

Treatment

Sex: Female, Male

Region of Enrollment

0 participants analyzed for the overall number of participants analyzed. The PI has retired and left the institution. Efforts were made to contact the PI but were unsuccessful. No study data are available for any results modules.

Oral niacin
nicotinic acid: niacin 1500 mg po qd
0 participants analyzed for the overall number of participants analyzed. The PI has retired and left the institution. Efforts were made to contact the PI but were unsuccessful. No study data are available for any results modules.

An Improvement in Vision in the the Treatment Patients, as Measured by an Increase of 15 Letters on the Early Treatment Diabetic Retinopathy Study (EDTRS) Vision Chart.

A Decrease in the Thickness of the Retina

Oral niacin
nicotinic acid: niacin 1500 mg po qd
0 participants started and completed in each arm/group. The PI has retired and left the institution. Efforts were made to contact the PI but were unsuccessful. No study data are available for any results modules.

Overall Study

Renee Kaneshiro

0 participants at risk (for each arm/group in both serious and other adverse events). The PI has retired and left the institution. Efforts were made to contact the PI but were unsuccessful. No study data are available for any results modules.

Adverse Events

Central Retinal Vein Occlusion

Branch Retinal Vein Occlusion

nicotinic acid

Palo Alto Medical Foundation Department of Ophthalmology

Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions

"Retrospective Study of Niacin (as a Vasodilator), Combined With a Topical Steroid (for Macular Edema), For CRVO, HRVO, BRVO."

Palo Alto Medical Foundation

Niacin 500mg TID PO for treatment of retinal vein occlusions.

Niacin 500mg TID PO for treatment of retinal vein occlusions.
Nicotinic acid: topical eye drops
Prednisolone acetate: topical eye drops

Prospective Active Treatment

improvement with combination of niacin and topical prednisolone acetate

Number of Participants With An Improvement in Vision, as Measured by an Increase of 15 Letters on the Early Treatment Diabetic Retinopathy Study (EDTRS) Vision Chart.

niacin/edema

Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions

To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions

科学に裏打ちされた最も完全な薬草データベース